Researchers have found that human papillomavirus (HPV) vaccines are highly effective at reducing cervical cancer-causing infections and can offer herd immunity, reinforcing previous research and ...

By leveraging the power of media, entertainment, and storytelling, we want to demystify HPV and cervical cancer, break the silence, and provide people with the knowledge and resources they need to ...

Did you know cervical cancer is the fourth most common cancer in women worldwide, with Sub-Saharan Africa carrying some of the highest rates? What makes this even more striking is that nearly all ...

The Ghana Health Service (GHS) in the Upper East Region, says cervical cancer is one of the leading causes of cancer-related deaths in women in Ghana and across the world.

Nairobi — Kenya is switching to a single-dose Human Papillomavirus (HPV) vaccine in a bold move aimed at eliminating cervical cancer and boosting access for girls aged 10 to 14 years. The shift -- ...

A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human ...

The human papillomavirus (HPV) is responsible for at least 95% of the 660,000 cervical cancer diagnoses globally. But US research shows the tremendous impact of ongoing vaccine programs. A vaccine ...

The Ghana Health Service (GHS) will from October 7 to 11, 2025, embark on a nationwide vaccination campaign targeting girls aged 11 to 14 years as part of efforts to curb the rising cases of cervical ...

Upstate University Hospital's "beneath the surFACE" program has a new goal to be aware and educated on health issues related to STIs.

A large, long-term study led by an Albert Einstein College of Medicine researcher has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in ...